📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
67
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split
65%
• 50-day avg $0.08 below $1 exchange minimum
• 6 months cash with weak price
💰 Capital Raise
15%
• Under 12 months cash (6mo)
💹 Market Data
Market Cap$52.79M
Shares Outstanding756.29M
Float133.67M
Cash$134.7K
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest6.1K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2015
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for HYOR
📊 HYOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 HYOR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.